Catalyst Pharmaceuticals, Inc. (CPRX)
31.18
+0.02
(+0.05%)
USD |
NASDAQ |
May 15, 16:00
31.18
0.00 (0.00%)
After-Hours: 17:46
Catalyst Pharmaceuticals EPS Diluted (Quarterly) : 0.5022 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 0.1889 |
| Inovio Pharmaceuticals, Inc. | -0.2848 |
| United Therapeutics Corp. | 5.824 |
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| Agios Pharmaceuticals, Inc. | -1.686 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 63.73M |
| Revenue (Quarterly) | 149.39M |
| Total Expenses (Quarterly) | 85.66M |
| Enterprise Value | 3.060B |
| Gross Profit Margin (Quarterly) | 83.82% |
| Profit Margin (Quarterly) | 42.66% |
| Earnings Yield | 5.58% |
| Operating Earnings Yield | 6.75% |
| Normalized Earnings Yield | 5.526 |